COMMUNIQUÉS West-GlobeNewswire

Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
14/11/2025
BRISBANE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing [...]
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
14/11/2025
REDWOOD CITY, CA, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the [...]
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
14/11/2025
Silver Spring, Md., Nov. 14, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is taking action to approve new labeling submitted by the company that includes the addition of a Boxed [...]
CROSSJECT lève 5 millions d'euros auprès de Vatel Capital
14/11/2025
Communiqué de presse CROSSJECT lève 5 millions d'euros auprès de Vatel Capital DIJON, France – 14 novembre 2025 (20H30 CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique de spécialités qui [...]
CROSSJECT completes €5 million financing with Vatel Capital
14/11/2025
Press release CROSSJECT completes €5 million financing with Vatel Capital DIJON, France – November 14th, 2025 (8.30 PM CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company that [...]
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
14/11/2025
WARREN, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced the filing of its quarterly report on Form 10-Q for the quarter ended September 30, [...]
Positioning Barbados as the Caribbean’s Life Sciences Hub
14/11/2025
EarlyHealth City to Anchor US$200 Million Investment BRIDGETOWN, Barbados, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed [...]
Fagron completes share buy-back program
14/11/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 14 November 2025 – 6PM CET Fagron completes share buy-back program In the period from 10 November 2025 through 14 November 2025, Fagron purchased 44, [...]
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
14/11/2025
Ghent Belgium, Nov. 14, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES PRESS RELEASE REGULATED INFORMATION 14 November 2025, 6 : 00 pm CET Ghent, Belgium, 14 [...]
Press Release Biocartis NV: Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025
14/11/2025
PRESS RELEASE, 11/14/2025, 10:00 AM EST Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025 Multiple abstracts and a corporate workshop highlight Idylla™’s growing role in oncology diagnostics Itasca, IL [...]
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
14/11/2025
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ MediPharm ” or the “ Company ”), a pharmaceutical company specialized in precision-based cannabinoids, today [...]
Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S
14/11/2025
Bagsværd, Denmark, 14 November 2025 - Today, Novo Nordisk A/S held its Extraordinary General Meeting, which was convened to elect new members of the Board of Directors. At the Extraordinary General Meeting, Helge Lund ( [...]
Wayman Place Partners with SafeSpace Global to Enhance Resident Safety with Non-Wearable Elopement Detection
14/11/2025
Knoxville, TN , Nov. 14, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC), a global leader in multimodal AI technology, is pleased to announce a partnership with Wayman Place, a trusted senior living [...]
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates
14/11/2025
Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trial Advanced DRP ® platform through new licensing [...]
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
14/11/2025
DUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today [...]
GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
14/11/2025
Phase 1 trial evaluating GTB-3650 TriKE ® for relapsed or refractory (r/r) CD33 expressing hematologic malignancies continues to actively enroll with the next update anticipated in Q1 2026 GTB-5550 TriKE ® IND [...]
Vaso Corporation Announces Financial Results for Third Quarter of 2025
14/11/2025
PLAINVIEW, N.Y., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales [...]
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
14/11/2025
Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activators Windtree received recent notification of allowed Istaroxime patents for acute heart failure in Canada [...]
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
14/11/2025
IM8’s Strong Unit Economics—60% Margins and 3.9-Month Payback—Central to Cantor’s Bullish Outlook Cantor Notes PRE’s ~$120M Liquidity and 387 BTC Treasury as Strengthening the Company’s Financial Position Cantor [...]

Pages